A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS)
Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, Sheela Tripathee et autres
2 citationsEuropean Urology Focus
Alexander Laird
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
363Publications signalées
10318Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
vaccines and immunoinformatics approachesPI3K/AKT/mTOR signaling in cancerRenal cell carcinoma treatmentImmunotherapy and Immune ResponsesPeptidase Inhibition and Analysis
Publications récentes
A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).
Ailbhe Lawlor, Mieke Van Hemelrijck, Charlotte Moss, Sheela Tripathee et autres
0 citationsApollo (University of Cambridge)
Data from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Supplementary Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Figure 3 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Figure 2 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Supplementary Figure 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Figure 5 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Figure 4 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Figure 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citations
Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma
Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong et autres
0 citationsCancer Research Communications
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.